Literature DB >> 17317018

Reinforcing effects of morphine are reduced in tissue plasminogen activator-knockout mice.

Y Yan1, K Yamada, H Mizoguchi, Y Noda, T Nagai, A Nitta, T Nabeshima.   

Abstract

Tissue plasminogen activator (tPA) plays a key role in neuroplasticity. We have recently demonstrated that the tPA-plasmin system is involved in the rewarding effects of drugs of abuse by regulating the release of dopamine in the nucleus accumbens. In the present study, we investigated whether tPA is involved in the reinforcing properties of morphine in a paradigm of drug self-administration. Eight-week-old tPA knockout and wild-type control mice were subjected to a single 24-h session of morphine self-administration under a fixed ratio (FR) 2 or a progressive ratio (PR) schedule of reinforcement after eight daily 30-min sessions of nose-poke training. tPA knockout mice responded significantly more often for morphine self-administration in a dose-dependent manner as compared with wild-type control mice. Under the PR schedule of morphine reinforcement, however, tPA knockout mice showed a lower breaking point than wild-type control mice. There was no significant difference in food-reinforced operant behavior, breaking points to food pellets, and saline self-administration between the two genotypes. The increased responding in tPA knockout mice under the FR2 schedule was significantly attenuated by the dopamine D1 receptor antagonist SCH23390 (0.3 mg/kg), whereas SCH23390, at a dose range of 0.03-2.0 mg/kg, demonstrated biphasic effects on morphine self-administration in wild-type control mice. Our findings suggest that the reinforcing effects of morphine are reduced in tPA knockout mice. Modulation of the tPA system in the brain may be a potential target against drugs of abuse.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17317018     DOI: 10.1016/j.neuroscience.2007.01.011

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  5 in total

Review 1.  Lentiviral vector-mediated gene transfer and RNA silencing technology in neuronal dysfunctions.

Authors:  Jean-Luc Dreyer
Journal:  Mol Biotechnol       Date:  2011-02       Impact factor: 2.695

Review 2.  Candidate gene polymorphisms predicting individual sensitivity to opioids.

Authors:  Shinya Kasai; Masakazu Hayashida; Ichiro Sora; Kazutaka Ikeda
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-11-13       Impact factor: 3.000

3.  Involvement of tissue plasminogen activator in stress responsivity during acute cocaine withdrawal in mice.

Authors:  Yan Zhou; Rajani Maiya; Erin H Norris; Mary Jeanne Kreek; Sidney Strickland
Journal:  Stress       Date:  2010-07-28       Impact factor: 3.493

4.  Tissue plasminogen activator contributes to morphine tolerance and induces mechanical allodynia via astrocytic IL-1β and ERK signaling in the spinal cord of mice.

Authors:  T Berta; Y-C Liu; Z-Z Xu; R-R Ji
Journal:  Neuroscience       Date:  2013-05-21       Impact factor: 3.590

Review 5.  A Glitch in the Matrix: The Role of Extracellular Matrix Remodeling in Opioid Use Disorder.

Authors:  Madelyn H Ray; Benjamin R Williams; Madeline K Kuppe; Camron D Bryant; Ryan W Logan
Journal:  Front Integr Neurosci       Date:  2022-06-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.